Your browser doesn't support javascript.
loading
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients.
Fiorino, G; Correale, C; Radice, S; Allocca, M; Furfaro, F; Gilardi, D; Nagore, D; Del Rio, L; Pascual, J; Martínez, A; Danese, S.
Afiliação
  • Fiorino G; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Correale C; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Radice S; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Allocca M; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Furfaro F; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Gilardi D; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Nagore D; R&D Department, Progenika SA, Derio, Spain.
  • Del Rio L; R&D Department, Progenika SA, Derio, Spain.
  • Pascual J; R&D Department, Progenika SA, Derio, Spain.
  • Martínez A; R&D Department, Progenika SA, Derio, Spain.
  • Danese S; Department of Gastroenterology, IBD Centre, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
Aliment Pharmacol Ther ; 46(9): 903-905, 2017 11.
Article em En | MEDLINE | ID: mdl-29023889
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infliximab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infliximab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2017 Tipo de documento: Article